Danaher Corp., US2358511028

Danaher stock: EUR 208.50, up 0.97% premarket

Published on 11/19/2026 at 08:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Danaher expects 4% to 5% core growth next year excluding respiratory products in China, with fuller guidance due in January. On Xetra, the stock closed at EUR 206.50 on Wednesday, November 18, 2026.

Danaher outlines its growth priorities

  • CEO Julie Brown presented commercial execution, innovation, talent and capital allocation as Danaher's main priorities at the Jefferies Global Healthcare Conference on November 17.
  • Danaher expects 4% to 5% core growth next year excluding respiratory products in China and plans to provide more detailed guidance in January.
  • Acquisitions remain the company's main capital-allocation priority after more than USD 11 billion of deployment this year, including Masimo and StatLab.
Danaher Corp., US2358511028, Illustration mit AI erstellt.

Danaher stock traded at 208.50 euros on Lang & Schwarz at 08:45 CET on Thursday, November 19, 2026, 0.97 percent above the Xetra close of Wednesday, November 18.

The life-sciences and diagnostics group is sharpening its growth strategy under CEO Julie Brown, who outlined the priorities at the Jefferies Global Healthcare Conference on Tuesday, November 17. The company is focusing on commercial execution, innovation, talent and capital allocation.

Growth outlook points to January

According to Investing.com, Brown described 4% to 5% core growth excluding respiratory products in China as a preliminary starting point for next year. More detailed guidance is expected in January after the company's planning process.

Danaher is also directing innovation spending toward areas with stronger growth potential. Annual innovation spending is about USD 1.7 billion, while management said diagnostics-focused priorities have lifted forecasted innovation-driven growth by 80%.

M&A remains the main capital-deployment priority. Danaher said it has deployed more than USD 11 billion this year, including the Masimo and StatLab acquisitions, which management expects to generate high-single-digit returns on invested capital by year five or earlier.

US equities are tracked in the S&P 500.

More news and analyses on Danaher stock.

Disclaimer...
en | US2358511028 | DANAHER CORP. | boerse | 70534539 | bgmi